Ibogaine comes from the root bark of a shrub native to Gabon, where the Bwiti use it as the sacred core of initiation ceremonies that can run for days. The film traces how that plant crossed into Western addiction treatment after Howard Lotsof, in the 1960s, noticed that a dose of ibogaine stopped his own heroin withdrawal cold, an accidental discovery that turned a ritual substance into an underground detox tool. Interviews and footage move between Bwiti practitioners describing the plant's place in Gabonese culture and researchers and former addicts describing its effects on opioid, cocaine, and alcohol dependence. The film notes that the FDA acknowledged promising signs from ibogaine as early as 1993, then follows the money question that stalled it there: a naturally occurring molecule that cannot be patented gives pharmaceutical companies little reason to fund the trials needed for approval. What emerges is less a drug story than a case study in how patent law and profit incentives decide which treatments reach patients and which stay confined to clinics operating outside the law.